Reverse glycoblotting allows rapid-enrichment glycoproteomics of biopharmaceuticals and disease-related biomarkers.
Kurogochi
Masaki
M
Division of Advanced Life Science, Graduate School of Advanced Life Science, Frontier Research Center for the Post-Genomic Science and Technology, Hokkaido University, N21, W11, Sapporo 001-0021, Japan.
Amano
Maho
M
Fumoto
Masataka
M
Takimoto
Akio
A
Kondo
Hirosato
H
Nishimura
Shin-Ichiro
S
D000595:Amino Acid Sequence; D000818:Animals; D015415:Biomarkers / Q000032:analysis* / Q000097:blood; D001702:Biopharmaceutics / Q000379:methods*; D003920:Diabetes Mellitus / Q000097:blood; D004921:Erythropoietin / Q000032:analysis; D005340:Fibrinogen / Q000032:analysis; D006020:Glycopeptides / Q000032:analysis*; D051379:Mice; D040901:Proteomics / Q000379:methods*; D011994:Recombinant Proteins; D000509:alpha-Fetoproteins / Q000032:analysis
D015415:Biomarkers; D006020:Glycopeptides; D011994:Recombinant Proteins; D000509:alpha-Fetoproteins; D004921:Erythropoietin; D005340:Fibrinogen